AMY SIMPSON: Open Payments
NPI 1407066806 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 28 payments from 9 companies in 2025. Trend: 2023 $304 · 2024 $459 · 2025 $523
Food & beverage: $331Education: $192
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $369 |
| Organon LLC | 1 | $31 |
| Galderma Laboratories, L.P. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Amgen Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
| Janssen Pharmaceuticals, Inc | 1 | $13 |
Products named: TREMFYA, VTAMA, AKLIEF, TALTZ, Otezla, Rhapsido, Sotyktu, SKYRIZI.
Industry payments across OR — which companies pay providers there.
